Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Sonnet BioTherapeutics (SONN) SEC Filings & 10K Form

Sonnet BioTherapeutics logo
$3.54 -0.22 (-5.85%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$3.50 -0.04 (-1.13%)
As of 08/15/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Sonnet BioTherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/01/2025
3:58 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
3:30 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
6:35 PM		Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		MCANDREW STEPHEN J (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
5:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
5:32 AM		Sonnet BioTherapeutics (Subject)
Form 425
07/02/2025
8:00 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
8:07 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:03 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:11 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
8:03 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
8:05 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:48 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:15 PM		Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2025
7:09 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2025
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
02/02/2025
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
01/31/2025
3:56 PM		Sonnet BioTherapeutics (Filer)
Form 424B3
01/31/2025
3:57 PM		Sonnet BioTherapeutics (Filer)
Form 424B3
01/30/2025
4:25 PM		Sonnet BioTherapeutics (Filer)
Form S-1/A
01/30/2025
4:25 PM		Sonnet BioTherapeutics (Filer)
Form S-1/A
01/28/2025
8:10 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
01/21/2025
8:17 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 424B3
01/13/2025
3:34 PM		Sonnet BioTherapeutics (Filer)
Form POS AM
12/23/2024
3:05 PM		Sonnet BioTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/17/2024
8:00 AM		Sonnet BioTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/17/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:25 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:20 AM		Sonnet BioTherapeutics (Filer)
Form 424B5
12/09/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
8:55 PM		Cross John Harry III (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New law could create $3.7 trillion tsunami. (Ad)

During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.

You can watch it right here.
12/05/2024
8:55 PM		Mohan Pankaj (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
8:20 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:15 PM		Sonnet BioTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/08/2024
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:22 AM		Sonnet BioTherapeutics (Filer)
Form 424B4
11/06/2024
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
11/06/2024
8:22 AM		Sonnet BioTherapeutics (Filer)
Form S-1/A
11/06/2024
7:48 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
8:01 AM		Sonnet BioTherapeutics (Filer)
Form S-1/A
10/28/2024
8:01 AM		Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/17/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:56 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
7:36 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:15 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:27 PM		Sonnet BioTherapeutics (Filer)
Form DEF 14A
08/19/2024
4:28 PM		Sonnet BioTherapeutics (Filer)
Form ARS
08/19/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SONN) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
"I'm risking my reputation on this"
A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...
Crypto 101 Media | Sponsored
But this $20 American company could control the secret
The "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...
The Oxford Club | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Cover all your expenses with just $118,000 invested?
Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...
Investors Alley | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored